Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
10.94
-0.02 (-0.18%)
May 29, 2025, 12:20 PM - Market open

Axogen Market Cap

Axogen has a market cap or net worth of $498.25 million as of May 29, 2025. Its market cap has increased by 98.27% in one year.

Market Cap
498.25M
Enterprise Value
549.46M
1-Year Change
98.27%
Ranking
Category
Stock Price
$10.94

Market Cap Chart

Since December 1, 1998, Axogen's market cap has increased from $12.20M to $498.25M, an increase of 3,984.03%. That is a compound annual growth rate of 15.02%.

History

DateMarket Cap% Change
May 28, 2025499.20M-31.17%
Dec 31, 2024725.30M146.70%
Dec 29, 2023294.00M-30.33%
Dec 30, 2022422.00M8.37%
Dec 31, 2021389.40M-45.79%
Dec 31, 2020718.30M1.73%
Dec 31, 2019706.10M-10.63%
Dec 31, 2018790.10M-16.55%
Dec 29, 2017946.80M219.76%
Dec 30, 2016296.10M98.19%
Dec 31, 2015149.40M113.43%
Dec 31, 201470.00M-10.14%
Dec 31, 201377.90M159.67%
Dec 31, 201230.00M1.35%
Dec 30, 201129.60M97.33%
Dec 31, 201015.00M-12.79%
Dec 31, 200917.20M45.76%
Dec 31, 200811.80M118.52%
Dec 31, 20075.40M100.00%
Dec 29, 20062.70M28.57%
Dec 30, 20052.10M-65.00%
Dec 31, 20046.00M87.50%
Dec 31, 20033.20M60.00%
Dec 31, 20022.00M-60.78%
Dec 31, 20015.10M-30.14%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 645.82B
Johnson & Johnson 366.76B
AbbVie 323.41B
Novo Nordisk 305.07B
UnitedHealth Group 270.43B
Abbott Laboratories 229.69B
AstraZeneca 219.74B
Novartis AG 219.70B
Market Cap Rankings